Global Colorectal Cancer Molecular Diagnostics Market 2025 by Company, Regions, Type and Application, Forecast to 2031

According to our (Global Info Research) latest study, the global Colorectal Cancer Molecular Diagnostics market size was valued at US$ 704 million in 2024 and is forecast to a readjusted size of USD 1727 million by 2031 with a CAGR of 13.8% during review period.

Colorectal Cancer Molecular Diagnostics refers to the use of molecular techniques to detect specific genetic mutations, biomarkers, and molecular alterations associated with colorectal cancer. These diagnostics help in identifying cancer subtypes, predicting the patient's response to treatment, and assessing the risk of cancer recurrence. Methods used in molecular diagnostics include polymerase chain reaction (PCR), next-generation sequencing (NGS), and fluorescence in situ hybridization (FISH), among others. By providing personalized information about the tumor’s genetic profile, molecular diagnostics enable targeted therapies and improve the precision of treatment plans for colorectal cancer patients.

Colorectal Cancer Molecular Diagnostics Market Drivers:

Rising Prevalence of Colorectal Cancer: As colorectal cancer remains one of the most common cancers globally, the growing number of cases is a key driver for the molecular diagnostics market. Early detection and personalized treatment approaches are increasingly in demand.

Advancements in Molecular Diagnostics Technology: Innovations like next-generation sequencing (NGS), liquid biopsy, and biomarker discovery have improved the accuracy and efficiency of diagnostics, making them more accessible and appealing to healthcare providers and patients.

Personalized Medicine and Targeted Therapies: The shift toward personalized treatment in oncology, where therapies are tailored based on the patient’s genetic profile, is driving the adoption of molecular diagnostics to identify specific mutations and biomarkers in colorectal cancer.

Increasing Awareness and Screening Programs: Governments and health organizations are promoting regular colorectal cancer screenings, driving the demand for advanced diagnostic tests.

Colorectal Cancer Molecular Diagnostics Market Challenges:

High Costs and Reimbursement Issues: Advanced molecular diagnostics can be expensive, and the lack of consistent reimbursement policies across different regions limits their widespread adoption, particularly in low- and middle-income countries.

Complexity of Genetic Data Interpretation: As molecular diagnostics provide a vast amount of genetic data, interpreting these results requires specialized expertise. This can create a barrier in regions where access to highly skilled professionals is limited.

Regulatory Hurdles: Stringent regulations surrounding the approval and clinical use of molecular diagnostics can slow down market growth, especially when it comes to introducing new and innovative tests.

Limited Awareness in Developing Regions: While awareness of colorectal cancer and molecular diagnostics is growing in developed countries, many developing regions still face challenges related to lack of awareness and infrastructure for advanced diagnostic techniques.

Global core colorectal cancer molecular diagnostics players include Roche Diagnostics, Abbott and Thermo Fisher etc. The top 3 companies hold a share about 45%. North America is the largest market with a share about 43%, followed by Asia-Pacific and Europe.

This report is a detailed and comprehensive analysis for global Colorectal Cancer Molecular Diagnostics market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.

Key Features:

Global Colorectal Cancer Molecular Diagnostics market size and forecasts, in consumption value ($ Million), 2020-2031

Global Colorectal Cancer Molecular Diagnostics market size and forecasts by region and country, in consumption value ($ Million), 2020-2031

Global Colorectal Cancer Molecular Diagnostics market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031

Global Colorectal Cancer Molecular Diagnostics market shares of main players, in revenue ($ Million), 2020-2025

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Colorectal Cancer Molecular Diagnostics

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Colorectal Cancer Molecular Diagnostics market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche Diagnostics, Abbott, Thermo Fisher, Qiagen, Illumina, Biomerieux, Bio-Rad, Agilent, Daangene, Amoydx, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market segmentation

Colorectal Cancer Molecular Diagnostics market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
Polymerase Chain Reaction PCR
Molecular Hybridization
Biochip
Others

Market segment by Application
Hospital
Third-Party Testing Agency
Others

Market segment by players, this report covers
Roche Diagnostics
Abbott
Thermo Fisher
Qiagen
Illumina
Biomerieux
Bio-Rad
Agilent
Daangene
Amoydx

Market segment by regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:

Chapter 1, to describe Colorectal Cancer Molecular Diagnostics product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top players of Colorectal Cancer Molecular Diagnostics, with revenue, gross margin, and global market share of Colorectal Cancer Molecular Diagnostics from 2020 to 2025.

Chapter 3, the Colorectal Cancer Molecular Diagnostics competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Colorectal Cancer Molecular Diagnostics market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.

Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.

Chapter 12, the key raw materials and key suppliers, and industry chain of Colorectal Cancer Molecular Diagnostics.

Chapter 13, to describe Colorectal Cancer Molecular Diagnostics research findings and conclusion.